Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.

See What's Going on With the Solar Industry

HALO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $4,666,350.00

Halozyme Therapeutics Insider Trading History Chart

Halozyme Therapeutics Share Price & Price History

^$51.84

▼ -0.81 (-1.54%)

As of 02/6/2023 05:31 PM ET

Days: 30 | 90 | 365

"We need batteries. Literally everywhere."

From Investing Trends | Ad

Pretty much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense."

Read about this company's once-in-a-lifetime offer

Halozyme Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/19/2023	Helen Torley	CEO	Sell	10,000	$52.41	$524,100.00	587,177
1/17/2023	Michael J. LaBarre	SVP	Sell	10,000	$50.46	$504,600.00	143,137
12/15/2022	Helen Torley	CEO	Sell	10,000	$57.37	$573,700.00	587,177
12/13/2022	Michael J. LaBarre	SVP	Sell	10,000	$58.67	$586,700.00	153,137
12/5/2022	Matthew L Posard	Director	Sell	10,000	$55.74	$557,400.00	115,189
12/2/2022	Matthew L Posard	Director	Sell	10,000	$58.80	$588,000.00	125,189
11/17/2022	Helen Torley	CEO	Sell	10,000	$52.15	$521,500.00	587,177
11/15/2022	Michael J. LaBarre	SVP	Sell	10,000	$54.13	$541,300.00	163,137
11/15/2022	Nicole Labrosse	CFO	Sell	5,000	$53.81	$269,050.00	4,045
11/8/2021	Helen Torley	CEO	Sell	50,000	$39.82	$1,991,000.00
11/5/2021	Connie Matsui	Director	Sell	32,000	$40.38	$1,292,160.00
10/4/2021	Helen Torley	CEO	Sell	50,000	$40.09	$2,004,500.00
10/1/2021	Michael J. LaBarre	SVP	Sell	29,450	$39.93	$1,175,938.50
9/7/2021	Helen Torley	CEO	Sell	50,000	$42.38	$2,119,000.00	587,160
8/25/2021	Jean-Pierre Bizzari	Director	Sell	35,000	$41.01	$1,435,350.00
8/10/2021	Helen Torley	CEO	Sell	50,000	$41.11	$2,055,500.00
7/6/2021	Helen Torley	CEO	Sell	50,000	$45.97	$2,298,500.00	587,160
7/1/2021	Michael J. LaBarre	SVP	Sell	40,315	$45.70	$1,842,395.50
6/7/2021	Helen Torley	CEO	Sell	50,000	$39.66	$1,983,000.00	587,160
5/11/2021	Helen Torley	CEO	Sell	50,000	$43.02	$2,151,000.00	587,160
4/14/2021	Kenneth J. Kelley	Director	Sell	5,000	$45.00	$225,000.00	179,833
4/5/2021	Helen Torley	CEO	Sell	50,000	$42.55	$2,127,500.00	587,160
4/1/2021	Michael J. LaBarre	SVP	Sell	28,689	$42.56	$1,221,003.84
3/1/2021	Helen Torley	CEO	Sell	50,000	$46.19	$2,309,500.00	587,160
3/1/2021	Kenneth J. Kelley	Director	Sell	5,000	$45.34	$226,700.00	185,333
3/1/2021	Michael J. LaBarre	SVP	Sell	18,324	$45.81	$839,422.44	129,330
2/1/2021	Helen Torley	CEO	Sell	50,000	$47.84	$2,392,000.00	520,522
2/1/2021	Kenneth J. Kelley	Director	Sell	5,000	$48.12	$240,600.00	190,079
1/4/2021	Kenneth J. Kelley	Director	Sell	5,000	$42.91	$214,550.00	195,123
12/21/2020	Michael J. LaBarre	SVP	Sell	12,000	$42.58	$510,960.00	123,400
12/7/2020	Kenneth J. Kelley	Director	Sell	35,086	$41.00	$1,438,526.00	199,833
12/2/2020	Kenneth J. Kelley	Director	Sell	31,792	$41.00	$1,303,472.00	234,919
11/27/2020	Kenneth J. Kelley	Director	Sell	10,000	$41.25	$412,500.00	276,711
11/25/2020	Helen Torley	CEO	Sell	50,000	$40.73	$2,036,500.00	530,522
11/25/2020	Jeffrey William Henderson	Director	Sell	24,498	$40.08	$981,879.84	47,609
11/20/2020	Michael J. LaBarre	SVP	Sell	12,000	$38.76	$465,120.00	142,689
10/20/2020	Michael J. LaBarre	SVP	Sell	12,000	$30.43	$365,160.00	146,800
9/21/2020	Michael J. LaBarre	SVP	Sell	12,000	$26.91	$322,920.00	158,800
9/11/2020	Connie Matsui	Director	Sell	32,000	$27.06	$865,920.00	216,753
8/20/2020	Michael J. LaBarre	SVP	Sell	12,000	$28.30	$339,600.00	170,800
8/13/2020	James M. Daly	Director	Sell	34,337	$29.12	$999,893.44	31,365
7/20/2020	Michael J. LaBarre	SVP	Sell	12,000	$29.01	$348,120.00	182,800
5/20/2020	Michael J. LaBarre	SVP	Sell	21,387	$23.80	$509,010.60	197,574
3/19/2020	Kenneth J. Kelley	Director	Buy	52,629	$14.23	$748,910.67	242,467

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

SEC Filings (Institutional Ownership Changes) for Halozyme Therapeutics (NASDAQ:HALO)

96.32% of Halozyme Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Halozyme Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/6/2023	Ifrah Financial Services Inc.	6,751	$0.38M	0.1%	-3.9%	0.005%
2/6/2023	Retirement Systems of Alabama	178,214	$10.14M	0.0%	-1.2%	0.132%
2/6/2023	Pacer Advisors Inc.	25,916	$1.48M	0.0%	+339.6%	0.019%
2/6/2023	Synovus Financial Corp	78,875	$4.49M	0.1%	+2.5%	0.058%
2/6/2023	Los Angeles Capital Management LLC	152,388	$8.67M	0.0%	-15.9%	0.113%
2/6/2023	Harvest Fund Management Co. Ltd	1,002	$57K	0.0%	N/A	0.001%
2/6/2023	Lisanti Capital Growth LLC	147,320	$8.38M	1.1%	N/A	0.109%
2/3/2023	Pzena Investment Management LLC	14,507	$0.83M	0.0%	N/A	0.011%
2/3/2023	Birchview Capital LP	10,000	$0.57M	0.4%	N/A	0.007%
2/3/2023	EFG Asset Management North America Corp.	124,572	$7.10M	1.6%	-17.4%	0.092%
2/3/2023	Fisher Asset Management LLC	435,917	$24.80M	0.0%	-36.7%	0.322%
2/3/2023	Mizuho Markets Americas LLC	275,268	$15.66M	0.9%	-23.3%	0.204%
2/2/2023	SG Americas Securities LLC	49,932	$2.84M	0.0%	-24.6%	0.037%
2/2/2023	Kornitzer Capital Management Inc. KS	305,349	$17.37M	0.4%	-31.8%	0.226%
2/2/2023	ProShare Advisors LLC	38,700	$2.20M	0.0%	+6.8%	0.029%
2/2/2023	HighMark Wealth Management LLC	41,790	$2.38M	1.8%	-13.8%	0.031%
2/1/2023	Bank of Montreal Can	315,973	$18.59M	0.0%	-26.8%	0.234%
2/1/2023	Meritage Portfolio Management	198,041	$11.27M	0.9%	-3.2%	0.146%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	20,206	$1.15M	0.0%	+8.7%	0.015%
2/1/2023	Janney Montgomery Scott LLC	8,290	$0.47M	0.0%	N/A	0.006%
2/1/2023	Tran Capital Management L.P.	1,084,118	$61.69M	7.8%	-4.8%	0.802%
2/1/2023	Vahanian & Associates Financial Planning Inc.	9,225	$0.53M	1.7%	N/A	0.007%
1/31/2023	Kestra Advisory Services LLC	5,285	$0.30M	0.0%	N/A	0.004%
1/31/2023	Cookson Peirce & Co. Inc.	46,272	$2.63M	0.2%	-9.1%	0.034%
1/31/2023	China Universal Asset Management Co. Ltd.	21,636	$1.23M	0.5%	-13.2%	0.016%
1/31/2023	Cabot Wealth Management Inc.	49,226	$2.80M	0.5%	+50.8%	0.036%
1/31/2023	Knights of Columbus Asset Advisors LLC	74,707	$4.25M	0.4%	-17.6%	0.055%
1/31/2023	Geneos Wealth Management Inc.	4,550	$0.26M	0.0%	+15.2%	0.003%
1/27/2023	Natixis Advisors L.P.	50,789	$2.89M	0.0%	+19.1%	0.038%
1/27/2023	State of Michigan Retirement System	34,438	$1.96M	0.0%	-0.9%	0.025%
1/27/2023	Arbor Investment Advisors LLC	17,950	$1.02M	0.2%	N/A	0.013%
1/26/2023	Comerica Bank	62,557	$3.19M	0.0%	-3.0%	0.046%
1/26/2023	Stephens Investment Management Group LLC	1,294,025	$73.73M	1.3%	-0.4%	0.957%
1/26/2023	Inspire Investing LLC	4,131	$0.24M	0.0%	-20.6%	0.003%
1/26/2023	Strs Ohio	26,500	$1.51M	0.0%	-39.8%	0.020%
1/26/2023	Dupont Capital Management Corp	10,644	$0.61M	0.0%	+3.7%	0.008%
1/25/2023	MGO One Seven LLC	11,033	$0.63M	0.1%	-2.9%	0.008%
1/25/2023	Fifth Third Bancorp	12,885	$0.73M	0.0%	-8.2%	0.010%
1/25/2023	Lindbrook Capital LLC	1,906	$0.11M	0.0%	-14.8%	0.001%
1/24/2023	Oak Ridge Investments LLC	93,066	$5.30M	0.8%	-2.2%	0.069%
1/24/2023	Louisiana State Employees Retirement System	36,200	$2.06M	0.1%	-1.4%	0.027%
1/24/2023	Park Avenue Securities LLC	7,668	$0.44M	0.0%	+16.3%	0.006%
1/24/2023	Centerpoint Advisors LLC	700	$40K	0.0%	-33.3%	0.001%
1/24/2023	Xponance Inc.	20,868	$1.19M	0.0%	-2.3%	0.015%
1/23/2023	Allspring Global Investments Holdings LLC	398,216	$22.66M	0.0%	-46.5%	0.295%
1/23/2023	Scout Investments Inc.	284,744	$16.20M	0.3%	-4.9%	0.211%
1/23/2023	Verdence Capital Advisors LLC	14,762	$0.84M	0.1%	-5.8%	0.011%
1/20/2023	Edmonds Duncan Registered Investment Advisors LLC	3,849	$0.22M	0.1%	N/A	0.003%
1/20/2023	Redwood Investments LLC	441,809	$25.14M	3.4%	-1.0%	0.327%
1/19/2023	Crossmark Global Holdings Inc.	18,928	$1.08M	0.0%	-18.1%	0.014%
1/18/2023	Bernzott Capital Advisors	444,728	$25.31M	3.3%	-2.4%	0.329%
1/18/2023	Private Advisor Group LLC	21,717	$1.22B	0.1%	-48.0%	0.016%
1/17/2023	Tealwood Asset Management Inc.	26,249	$1.49M	0.8%	-8.1%	0.019%
1/13/2023	Cooper Financial Group	7,378	$0.42M	0.1%	+6.3%	0.005%
1/12/2023	Titleist Asset Management LTD.	4,794	$0.27M	0.1%	N/A	0.004%
1/12/2023	First Hawaiian Bank	27,285	$1.55M	0.1%	-14.6%	0.020%
1/12/2023	Assenagon Asset Management S.A.	158,671	$9.03M	0.0%	+1,038.6%	0.117%
1/10/2023	Coldstream Capital Management Inc.	4,930	$0.28M	0.0%	N/A	0.004%
1/9/2023	Yousif Capital Management LLC	71,948	$4.09M	0.1%	+1.7%	0.053%
12/22/2022	Bernzott Capital Advisors	455,583	$18.01M	2.5%	+22.2%	0.337%
12/9/2022	Penn Capital Management Company LLC	315,584	$12.53M	1.4%	+5.3%	0.233%
11/22/2022	Teachers Retirement System of The State of Kentucky	26,090	$1.03M	0.0%	N/A	0.019%
11/21/2022	California State Teachers Retirement System	180,054	$7.12M	0.0%	-1.0%	0.133%
11/17/2022	M&T Bank Corp	101,277	$4.01M	0.0%	-1.0%	0.075%
11/16/2022	Glenmede Trust Co. NA	384,599	$15.21M	0.1%	-10.8%	0.284%
11/16/2022	Advisory Research Inc.	37,915	$1.50M	0.1%	+6.6%	0.028%
11/16/2022	Almanack Investment Partners LLC.	1,382	$55K	0.0%	N/A	0.001%
11/16/2022	Alpha Paradigm Partners LLC	23,099	$0.91M	0.4%	N/A	0.017%
11/16/2022	Balyasny Asset Management LLC	119,406	$4.72M	0.0%	N/A	0.088%
11/16/2022	Baird Financial Group Inc.	72,114	$2.85M	0.0%	+2.0%	0.053%
11/16/2022	Verity Asset Management Inc.	31,888	$1.26M	1.3%	N/A	0.024%
11/16/2022	BNP Paribas Arbitrage SNC	153,911	$6.09M	0.0%	-96.1%	0.114%
11/15/2022	Neuberger Berman Group LLC	178,261	$7.05M	0.0%	+1.7%	0.132%
11/15/2022	Alliancebernstein L.P.	912,099	$36.06M	0.0%	-7.3%	0.675%
11/15/2022	Castleark Management LLC	216,750	$8.57M	0.5%	+6.3%	0.160%
11/15/2022	Pier Capital LLC	172,451	$6.82M	1.2%	N/A	0.128%
11/15/2022	Colony Group LLC	80,023	$3.16M	0.1%	-1.6%	0.059%
11/15/2022	Mercer Global Advisors Inc. ADV	16,636	$0.66M	0.0%	-12.0%	0.012%
11/15/2022	Thrivent Financial for Lutherans	1,317,732	$52.10M	0.1%	-0.6%	0.975%
11/15/2022	Two Sigma Advisers LP	331,600	$13.11M	0.0%	-15.0%	0.245%
11/15/2022	Two Sigma Investments LP	107,139	$4.24M	0.0%	-81.2%	0.079%
11/15/2022	UBS Asset Management Americas Inc.	519,951	$20.56M	0.0%	+194.0%	0.385%
11/15/2022	Vanguard Group Inc.	13,335,155	$527.27M	0.0%	+0.3%	9.862%
11/15/2022	Pathstone Family Office LLC	5,382	$0.21M	0.0%	-4.6%	0.004%
11/15/2022	Price T Rowe Associates Inc. MD	1,615,020	$63.86M	0.0%	+3.3%	1.194%
11/15/2022	Martingale Asset Management L P	12,817	$0.51M	0.0%	+145.5%	0.009%
11/15/2022	ETF Managers Group LLC	42,106	$1.67M	0.1%	N/A	0.031%
11/15/2022	Edgestream Partners L.P.	55,732	$2.20M	0.2%	N/A	0.041%
11/15/2022	Federated Hermes Inc.	73,841	$2.92M	0.0%	-11.6%	0.055%
11/15/2022	First Trust Advisors LP	111,093	$4.39M	0.0%	+38.1%	0.082%
11/15/2022	Financial Advocates Investment Management	6,421	$0.54M	0.0%	N/A	0.005%
11/15/2022	First Light Asset Management LLC	932,244	$36.86M	3.7%	-1.0%	0.689%
11/15/2022	Bayesian Capital Management LP	16,100	$0.64M	0.1%	-19.1%	0.012%
11/15/2022	Bellevue Group AG	930,500	$36.79M	0.5%	-4.2%	0.688%
11/15/2022	Bison Wealth LLC	20,183	$0.80M	0.3%	N/A	0.015%
11/14/2022	United Capital Financial Advisers LLC	8,995	$0.36M	0.0%	-48.5%	0.007%
11/14/2022	AlphaCrest Capital Management LLC	10,972	$0.43M	0.0%	-74.9%	0.008%
11/14/2022	Macquarie Group Ltd.	2,554,967	$101.07M	0.1%	+1.4%	1.890%
11/14/2022	Segall Bryant & Hamill LLC	190,707	$7.54M	0.1%	N/A	0.141%
11/14/2022	Royal Bank of Canada	425,952	$16.84M	0.0%	-91.6%	0.315%

Data available starting January 2016

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.

Today's Range

Now: $51.84

$51.82

$53.13

50 Day Range

MA: $54.96

$50.34

$59.44

52 Week Range

Now: $51.84

$32.00

$59.46

Volume

711,974 shs

Average Volume

1,304,199 shs

Market Capitalization

$7.01 billion

P/E Ratio

34.79

Dividend Yield

N/A

Beta

1.22

Who are the company insiders with the largest holdings of Halozyme Therapeutics?: Halozyme Therapeutics' top insider shareholders include:
Helen Torley (CEO)
Kenneth J Kelley (Director)
Michael J Labarre (SVP)
Matthew L Posard (Director)
Nicole Labrosse (CFO)
Connie Matsui (Director)
Jean-Pierre Bizzari (Director)
Learn More about top insider investors at Halozyme Therapeutics.
Who are the major institutional investors of Halozyme Therapeutics?: Halozyme Therapeutics' top institutional investors include:
Stephens Investment Management Group LLC — 0.96%
Tran Capital Management L.P. — 0.80%
Bernzott Capital Advisors — 0.33%
Redwood Investments LLC — 0.33%
Fisher Asset Management LLC — 0.32%
Allspring Global Investments Holdings LLC — 0.29%
Learn More about top institutional investors of Halozyme Therapeutics stock.
Which major investors are selling Halozyme Therapeutics stock?: Within the last quarter, HALO stock was sold by these institutional investors:
Allspring Global Investments Holdings LLC
Fisher Asset Management LLC
Kornitzer Capital Management Inc. KS
Bank of Montreal Can
Mizuho Markets Americas LLC
Tran Capital Management L.P.
Los Angeles Capital Management LLC
EFG Asset Management North America Corp.
In the last year, company insiders that have sold Halozyme Therapeutics company stock include:
Helen Torley (CEO)
Kenneth J Kelley (Director)
Michael J Labarre (SVP)
Matthew L Posard (Director)
Learn More investors selling Halozyme Therapeutics stock.
Which major investors are buying Halozyme Therapeutics stock?: Within the last quarter, HALO stock was acquired by institutional investors including:
Lisanti Capital Growth LLC
Assenagon Asset Management S.A.
Pacer Advisors Inc.
Arbor Investment Advisors LLC
Cabot Wealth Management Inc.
Pzena Investment Management LLC
Birchview Capital LP
Vahanian & Associates Financial Planning Inc.

Profit From the Commercial Solar Boom?